Sacral neuromodulation therapy for urinary and defecatory disorders: experience in a Latin American public hospital

dc.contributor.authorMass-Lindenbaum, Marcelo
dc.contributor.authorArevalo-Vega, Diego
dc.contributor.authorAleuanlli, Isidora
dc.contributor.authorSantis-Moya, Fernanda
dc.contributor.authorMaluenda, Andrea
dc.contributor.authorDines, Eitan
dc.contributor.authorCohen-Vaizer, Miriam
dc.contributor.authorSaavedra, Alvaro
dc.contributor.authorRaby, Trinidad
dc.contributor.authorBlumel, Bernardita
dc.contributor.authorCuevas, Rodrigo
dc.contributor.authorPohlhammer, Simone
dc.contributor.authorAlarcon, Gabriela
dc.contributor.authorAlbornoz, Marco Arellano
dc.contributor.authorPizarro-Berdichevsky, Javier
dc.date.accessioned2025-01-20T16:08:46Z
dc.date.available2025-01-20T16:08:46Z
dc.date.issued2024
dc.description.abstractObjective: To To show the experience of a Latin American public hospital, with SNM in the management of either OAB, NOUR or FI, reporting feasibility, short to medium-term success rates, and complications. Methods: A retrospective cohort was conducted using data collected prospectively from patients with urogynecological conditions and referred from colorectal surgery and urology services between 2015 and 2022. Results: Advanced or basic trial phases were performed on 35 patients, 33 [94%] of which were successful and opted to move on Implantable Pulse Generator [GG] implantation. The average follow-up time after definitive implantation was 82 months (SD 59]. Of the 33 patients undergoing, 27 (81%]reported an improvement of 50% or more in their symptoms at last follow-up. Moreover, 30 patients (90%] with a definitive implant reported subjective improvement, with an average PGI-I "much better" and 9 of them reporting to be "excellent" on PGI-I. Conclusion: SNM is a feasible and effective treatment for pelvic floor dysfunction. Its implementation requires highly trained groups and innovative leadership. At a nation-wide level, greater diffusion of this therapy among professionals is needed to achieve timely referral of patients who require it.
dc.fuente.origenWOS
dc.identifier.doi10.61622/rbgo/2024AO11
dc.identifier.eissn1806-9339
dc.identifier.issn0100-7203
dc.identifier.urihttps://doi.org/10.61622/rbgo/2024AO11
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/90104
dc.identifier.wosidWOS:001312724000001
dc.language.isoen
dc.revistaRevista brasileira de ginecologia e obstetricia
dc.rightsacceso restringido
dc.subjectSacral neuromodulation
dc.subjectUrinary bladder
dc.subjectNon-obstructive urinary retention
dc.subjectFecal incontinence
dc.subjectIncontinence
dc.subjectElectric stimulation therapy
dc.subjectoveractive
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleSacral neuromodulation therapy for urinary and defecatory disorders: experience in a Latin American public hospital
dc.typeartículo
dc.volumen46
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files